Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Highly Regulated (List I)
ANTAPAM
20MG/2ML/IV/IM Injectable Solution/CHLORHYDRATE DE NEFOPAM
ManufacturerVerified lab
LES FRATER RAZES
Public retail price
N/ADZD
Identification
- Active ingredient (INN)
- CHLORHYDRATE DE NEFOPAM
- Internal code
- 03 H 112
- Country of Origin
- Algeria
- Pharmaceutical form
- IV/IM Injectable Solution
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/05amp de 2ml+b/50amp de 2ml
Clinical View
Highly Regulated (List I)
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering.
Nefopam has been investigated for the prevention of Kidney Transplantation.
Indications
Not Available
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.